메뉴 건너뛰기
Journal of Virology
Volumn 80, Issue 10, 2006, Pages 4758-4770
Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite suppressors or selection of plasma virus variants in patients on highly active antiretroviral therapy
Author keywords

[No Author keywords available]
Indexed keywords

NEUTRALIZING ANTIBODY;
EID: 33646453478     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.80.10.4758-4770.2006     Document Type: Article
Times cited : (145)
References (64)
  • 1
    • 0025267919 scopus 로고
    • Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera
    • Albert, J., B. Abrahamsson, K. Nagy, E. Aurelius, H. Gaines, G. Nystrom, and E. M. Fenyo. 1990. Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera. AIDS 4:107-112.
    • (1990) AIDS , vol.4 , pp. 107-112
    • Albert, J.1    Abrahamsson, B.2    Nagy, K.3    Aurelius, E.4    Gaines, H.5    Nystrom, G.6    Fenyo, E.M.7
  • 3
    • 0033823590 scopus 로고    scopus 로고
    • The effect of highly active antiretroviral therapy on binding and neutralizing antibody responses to human immunodeficiency virus type 1 infection
    • Binley, J. M., A. Trkola, T. Ketas, D. Schiller, B. Clas, S. Little, D. Richman, A. Hurley, M. Markowitz, and J. P. Moore. 2000. The effect of highly active antiretroviral therapy on binding and neutralizing antibody responses to human immunodeficiency virus type 1 infection. J. Infect. Dis. 182:945-949.
    • (2000) J. Infect. Dis. , vol.182 , pp. 945-949
    • Binley, J.M.1    Trkola, A.2    Ketas, T.3    Schiller, D.4    Clas, B.5    Little, S.6    Richman, D.7    Hurley, A.8    Markowitz, M.9    Moore, J.P.10
  • 4
    • 0033046857 scopus 로고    scopus 로고
    • Neutralization escape in human immunodeficiency virus type 1-infected long-term nonprogressors
    • Bradney, A. P., S. Scheer, J. M. Crawford, S. P. Buchbinder, and D. C. Montefiori. 1999. Neutralization escape in human immunodeficiency virus type 1-infected long-term nonprogressors. J. Infect. Dis. 179:1264-1267.
    • (1999) J. Infect. Dis. , vol.179 , pp. 1264-1267
    • Bradney, A.P.1    Scheer, S.2    Crawford, J.M.3    Buchbinder, S.P.4    Montefiori, D.C.5
  • 5
    • 0027315125 scopus 로고
    • Simian immunodeficiency virus mutants resistant to serum neutralization arise during persistent infection of rhesus monkeys
    • Burns, D. P., C. Collignon, and R. C. Desrosiers. 1993. Simian immunodeficiency virus mutants resistant to serum neutralization arise during persistent infection of rhesus monkeys. J. Virol. 67:4104-4113.
    • (1993) J. Virol. , vol.67 , pp. 4104-4113
    • Burns, D.P.1    Collignon, C.2    Desrosiers, R.C.3
  • 6
    • 0036719574 scopus 로고    scopus 로고
    • Antibodies, viruses and vaccines
    • Burton, D. R. 2002. Antibodies, viruses and vaccines. Nat. Rev. Immunol. 2:706-713.
    • (2002) Nat. Rev. Immunol. , vol.2 , pp. 706-713
    • Burton, D.R.1
  • 7
    • 0028847578 scopus 로고
    • Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection
    • Cao, Y., L. Qin, L. Zhang, J. Safrit, and D. D. Ho. 1995. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N. Engl. J. Med. 332:201-208.
    • (1995) N. Engl. J. Med. , vol.332 , pp. 201-208
    • Cao, Y.1    Qin, L.2    Zhang, L.3    Safrit, J.4    Ho, D.D.5
  • 8
    • 13844302894 scopus 로고    scopus 로고
    • Structure of an unliganded simian immunodeficiency virus gp120 core
    • Chen, B., E. M. Vogan, H. Gong, J. J. Skehel, D. C. Wiley, and S. C. Harrison. 2005. Structure of an unliganded simian immunodeficiency virus gp120 core. Nature 433:834-841.
    • (2005) Nature , vol.433 , pp. 834-841
    • Chen, B.1    Vogan, E.M.2    Gong, H.3    Skehel, J.J.4    Wiley, D.C.5    Harrison, S.C.6
  • 9
    • 18144397438 scopus 로고    scopus 로고
    • Selection for human immunodeficiency virus type 1 envelope glycosylation variants with shorter V1-V2 loop sequences occurs during transmission of certain genetic subtypes and may impact viral RNA levels
    • Chohan, B., D. Lang, M. Sagar, B. Korber, L. Lavreys, B. Richardson, and J. Overbaugh. 2005. Selection for human immunodeficiency virus type 1 envelope glycosylation variants with shorter V1-V2 loop sequences occurs during transmission of certain genetic subtypes and may impact viral RNA levels. J. Virol. 79:6528-6531.
    • (2005) J. Virol. , vol.79 , pp. 6528-6531
    • Chohan, B.1    Lang, D.2    Sagar, M.3    Korber, B.4    Lavreys, L.5    Richardson, B.6    Overbaugh, J.7
  • 11
    • 0032555117 scopus 로고    scopus 로고
    • Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection
    • Chun, T. W., D. Engel, M. M. Berrey, T. Shea, L. Corey, and A. S. Fauci. 1998. Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection. Proc. Natl. Acad. Sci. USA 95:8869-8873.
    • (1998) Proc. Natl. Acad. Sci. USA , vol.95 , pp. 8869-8873
    • Chun, T.W.1    Engel, D.2    Berrey, M.M.3    Shea, T.4    Corey, L.5    Fauci, A.S.6
  • 12
    • 0028792184 scopus 로고
    • In vivo fate of HIV-1-infected T cells: Quantitative analysis of the transition to stable latency
    • Chun, T. W., D. Finzi, J. Margolick, K. Chadwick, D. Schwartz, and R. F. Siliciano. 1995. In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency. Nat. Med. 1:1284-1290.
    • (1995) Nat. Med. , vol.1 , pp. 1284-1290
    • Chun, T.W.1    Finzi, D.2    Margolick, J.3    Chadwick, K.4    Schwartz, D.5    Siliciano, R.F.6
  • 18
    • 18144429071 scopus 로고    scopus 로고
    • Characterization of human immunodeficiency virus type 1 (HIV-1) envelope variation and neutralizing antibody responses during transmission of HIV-1 subtype B
    • Frost, S. D., Y. Liu, S. L. Pond, C. Chappey, T. Wrin, C. J. Petropoulos, S. J. Little, and D. D. Richman. 2005. Characterization of human immunodeficiency virus type 1 (HIV-1) envelope variation and neutralizing antibody responses during transmission of HIV-1 subtype B. J. Virol. 79:6523-6527.
    • (2005) J. Virol. , vol.79 , pp. 6523-6527
    • Frost, S.D.1    Liu, Y.2    Pond, S.L.3    Chappey, C.4    Wrin, T.5    Petropoulos, C.J.6    Little, S.J.7    Richman, D.D.8
  • 20
    • 3543078012 scopus 로고    scopus 로고
    • HIV and SIV CTL escape: Implications for vaccine design
    • Goulder, P. J., and D. I. Watkins. 2004. HIV and SIV CTL escape: implications for vaccine design. Nat. Rev. Immunol. 4:630-640.
    • (2004) Nat. Rev. Immunol. , vol.4 , pp. 630-640
    • Goulder, P.J.1    Watkins, D.I.2
  • 24
    • 0036181249 scopus 로고    scopus 로고
    • Viral persistence: HIV's strategies of immune system evasion
    • Johnson, W. E., and R. C. Desrosiers. 2002. Viral persistence: HIV's strategies of immune system evasion. Annu. Rev. Med. 53:499-518.
    • (2002) Annu. Rev. Med. , vol.53 , pp. 499-518
    • Johnson, W.E.1    Desrosiers, R.C.2
  • 27
    • 0019296687 scopus 로고
    • A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences
    • Kimura, M. 1980. A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J. Mol. Evol. 16:111-120.
    • (1980) J. Mol. Evol. , vol.16 , pp. 111-120
    • Kimura, M.1
  • 28
    • 0036138443 scopus 로고    scopus 로고
    • Reconstitution of spontaneous neutralizing antibody response against autologous human immunodeficiency virus during highly active antiretroviral therapy
    • Kimura, T., K. Yoshimura, K. Nishihara, Y. Maeda, S. Matsumi, A. Koito, and S. Matsushita. 2002. Reconstitution of spontaneous neutralizing antibody response against autologous human immunodeficiency virus during highly active antiretroviral therapy. J. Infect. Dis. 185:53-60.
    • (2002) J. Infect. Dis. , vol.185 , pp. 53-60
    • Kimura, T.1    Yoshimura, K.2    Nishihara, K.3    Maeda, Y.4    Matsumi, S.5    Koito, A.6    Matsushita, S.7
  • 30
    • 0032543307 scopus 로고    scopus 로고
    • Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
    • Kwong, P. D., R. Wyatt, J. Robinson, R. W. Sweet, J. Sodroski, and W. A. Hendrickson. 1998. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 393:648-659.
    • (1998) Nature , vol.393 , pp. 648-659
    • Kwong, P.D.1    Wyatt, R.2    Robinson, J.3    Sweet, R.W.4    Sodroski, J.5    Hendrickson, W.A.6
  • 33
    • 0028834461 scopus 로고
    • A trimeric structural domain of the HIV-1 transmembrane glycoprotein
    • Lu, M., S. C. Blacklow, and P. S. Kim. 1995. A trimeric structural domain of the HIV-1 transmembrane glycoprotein. Nat. Struct. Biol. 2:1075-1082.
    • (1995) Nat. Struct. Biol. , vol.2 , pp. 1075-1082
    • Lu, M.1    Blacklow, S.C.2    Kim, P.S.3
  • 34
    • 27744438453 scopus 로고    scopus 로고
    • + lymphocytes cooperate to control acute simian immunodeficiency virus/human immunodeficiency virus chimeric virus infections in rhesus monkeys: Modulation by major histocompatibility complex genotype
    • + lymphocytes cooperate to control acute simian immunodeficiency virus/human immunodeficiency virus chimeric virus infections in rhesus monkeys: modulation by major histocompatibility complex genotype. J. Virol. 79:14887-14898.
    • (2005) J. Virol. , vol.79 , pp. 14887-14898
    • Mao, H.1    Lafont, B.A.2    Igarashi, T.3    Nishimura, Y.4    Brown, C.5    Hirsch, V.6    Buckler-White, A.7    Sadjadpour, R.8    Martin, M.A.9
  • 35
    • 23244467373 scopus 로고    scopus 로고
    • Recommendations for the design and use of standard virus panels to assess neutralizing antibody responses elicited by candidate human immunodeficiency virus type 1 vaccines
    • Mascola, J. R., P. D'Souza, P. Gilbert, B. H. Hahn, N. L. Haigwood, L. Morris, C. J. Petropoulos, V. R. Polonis, M. Sarzotti, and D. C. Montefiori. 2005. Recommendations for the design and use of standard virus panels to assess neutralizing antibody responses elicited by candidate human immunodeficiency virus type 1 vaccines. J. Virol. 79:10103-10107.
    • (2005) J. Virol. , vol.79 , pp. 10103-10107
    • Mascola, J.R.1    D'Souza, P.2    Gilbert, P.3    Hahn, B.H.4    Haigwood, N.L.5    Morris, L.6    Petropoulos, C.J.7    Polonis, V.R.8    Sarzotti, M.9    Montefiori, D.C.10
  • 39
    • 0030057730 scopus 로고    scopus 로고
    • Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors
    • Montefiori, D. C., G. Pantaleo, L. M. Fink, J. T. Zhou, J. Y. Zhou, M. Bilska, G. D. Miralles, and A. S. Fauci. 1996. Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors. J. Infect. Dis. 173:60-67.
    • (1996) J. Infect. Dis. , vol.173 , pp. 60-67
    • Montefiori, D.C.1    Pantaleo, G.2    Fink, L.M.3    Zhou, J.T.4    Zhou, J.Y.5    Bilska, M.6    Miralles, G.D.7    Fauci, A.S.8
  • 40
    • 0028917784 scopus 로고
    • Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120
    • Moore, J. P., Y. Cao, L. Qing, Q. J. Sattentau, J. Pyati, R. Koduri, J. Robinson, C. F. Barbas III, D. R. Burton, and D. D. Ho. 1995. Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120. J. Virol. 69:101-109.
    • (1995) J. Virol. , vol.69 , pp. 101-109
    • Moore, J.P.1    Cao, Y.2    Qing, L.3    Sattentau, Q.J.4    Pyati, J.5    Koduri, R.6    Robinson, J.7    Barbas III, C.F.8    Burton, D.R.9    Ho, D.D.10
  • 44
    • 0036340605 scopus 로고    scopus 로고
    • Molecular characterization of preintegration latency in human immunodeficiency virus type 1 infection
    • Pierson, T. C., Y. Zhou, T. L. Kieffer, C. T. Ruff, C. Buck, and R. F. Siliciano. 2002. Molecular characterization of preintegration latency in human immunodeficiency virus type 1 infection. J. Virol. 76:8518-8531.
    • (2002) J. Virol. , vol.76 , pp. 8518-8531
    • Pierson, T.C.1    Zhou, Y.2    Kieffer, T.L.3    Ruff, C.T.4    Buck, C.5    Siliciano, R.F.6
  • 46
    • 2342644898 scopus 로고    scopus 로고
    • The V1/V2 domain of gp120 is a global regulator of the sensitivity of primary human immunodeficiency virus type 1 isolates to neutralization by antibodies commonly induced upon infection
    • Pinter, A., W. J. Honnen, Y. He, M. K. Gorny, S. Zolla-Pazner, and S. C. Kayman. 2004. The V1/V2 domain of gp120 is a global regulator of the sensitivity of primary human immunodeficiency virus type 1 isolates to neutralization by antibodies commonly induced upon infection. J. Virol. 78:5205-5215.
    • (2004) J. Virol. , vol.78 , pp. 5205-5215
    • Pinter, A.1    Honnen, W.J.2    He, Y.3    Gorny, M.K.4    Zolla-Pazner, S.5    Kayman, S.C.6
  • 48
    • 0031749469 scopus 로고    scopus 로고
    • A role for carbohydrates in immune evasion in AIDS
    • Reitter, J. N., R. E. Means, and R. C. Desrosiers. 1998. A role for carbohydrates in immune evasion in AIDS. Nat. Med. 4:679-684.
    • (1998) Nat. Med. , vol.4 , pp. 679-684
    • Reitter, J.N.1    Means, R.E.2    Desrosiers, R.C.3
  • 49
    • 0024040544 scopus 로고
    • Generation of a neutralization-resistant variant of HIV-1 is due to selection for a point mutation in the envelope gene
    • Reitz, M. S., Jr., C. Wilson, C. Naugle, R. C. Gallo, and M. Robert-Guroff. 1988. Generation of a neutralization-resistant variant of HIV-1 is due to selection for a point mutation in the envelope gene. Cell 54:57-63.
    • (1988) Cell , vol.54 , pp. 57-63
    • Reitz Jr., M.S.1    Wilson, C.2    Naugle, C.3    Gallo, R.C.4    Robert-Guroff, M.5
  • 50
    • 0037389643 scopus 로고    scopus 로고
    • Rapid evolution of the neutralizing antibody response to HIV type 1 infection
    • Richman, D. D., T. Wrin, S. J. Little, and C. J. Petropoulos. 2003. Rapid evolution of the neutralizing antibody response to HIV type 1 infection. Proc. Natl. Acad. Sci. USA 100:4144-4149.
    • (2003) Proc. Natl. Acad. Sci. USA , vol.100 , pp. 4144-4149
    • Richman, D.D.1    Wrin, T.2    Little, S.J.3    Petropoulos, C.J.4
  • 51
    • 0036720438 scopus 로고    scopus 로고
    • Persistence of wild-type virus and lack of temporal structure in the latent reservoir for human immunodeficiency virus type 1 in pediatric patients with extensive antiretroviral exposure
    • Ruff, C. T., S. C. Ray, P. Kwon, R. Zinn, A. Pendleton, N. Hutton, R. Ashworth, S. Gange, T. C. Quinn, R. F. Siliciano, and D. Persaud. 2002. Persistence of wild-type virus and lack of temporal structure in the latent reservoir for human immunodeficiency virus type 1 in pediatric patients with extensive antiretroviral exposure. J. Virol. 76:9481-9492.
    • (2002) J. Virol. , vol.76 , pp. 9481-9492
    • Ruff, C.T.1    Ray, S.C.2    Kwon, P.3    Zinn, R.4    Pendleton, A.5    Hutton, N.6    Ashworth, R.7    Gange, S.8    Quinn, T.C.9    Siliciano, R.F.10    Persaud, D.11
  • 53
    • 24644493206 scopus 로고    scopus 로고
    • Human immunodeficiency virus type 1 variants isolated from single plasma samples display a wide spectrum of neutralization sensitivity
    • Skrabal, K., S. Saragosti, J. L. Labernardiere, F. Barin, F. Clavel, and F. Mammano. 2005. Human immunodeficiency virus type 1 variants isolated from single plasma samples display a wide spectrum of neutralization sensitivity. J. Virol. 79:11848-11857.
    • (2005) J. Virol. , vol.79 , pp. 11848-11857
    • Skrabal, K.1    Saragosti, S.2    Labernardiere, J.L.3    Barin, F.4    Clavel, F.5    Mammano, F.6
  • 54
    • 22544461340 scopus 로고    scopus 로고
    • Evidence that low-level viremias during effective highly active antiretroviral therapy result from two processes: Expression of archival virus and replication of virus
    • Tobin, N. H., G. H. Learn, S. E. Holte, Y. Wang, A. J. Melvin, J. L. McKernan, D. M. Pawluk, K. M. Mohan, P. F. Lewis, J. I. Mullins, and L. M. Frenkel. 2005. Evidence that low-level viremias during effective highly active antiretroviral therapy result from two processes: expression of archival virus and replication of virus. J. Virol. 79:9625-9634.
    • (2005) J. Virol. , vol.79 , pp. 9625-9634
    • Tobin, N.H.1    Learn, G.H.2    Holte, S.E.3    Wang, Y.4    Melvin, A.J.5    McKernan, J.L.6    Pawluk, D.M.7    Mohan, K.M.8    Lewis, P.F.9    Mullins, J.I.10    Frenkel, L.M.11
  • 55
    • 0025161606 scopus 로고
    • Neutralization of multiple HIV-1 isolates from a single subject by autologous sequential sera
    • Tremblay, M., and M. A. Wainberg. 1990. Neutralization of multiple HIV-1 isolates from a single subject by autologous sequential sera. J. Infect. Dis. 162:735-737.
    • (1990) J. Infect. Dis. , vol.162 , pp. 735-737
    • Tremblay, M.1    Wainberg, M.A.2
  • 57
    • 0043169671 scopus 로고    scopus 로고
    • First demonstration of a lack of viral sequence evolution in a nonprogressor, denning replication-incompetent HIV-1 infection
    • Wang, B., M. Mikhail, W. B. Dyer, J. J. Zaunders, A. D. Kelleher, and N. K. Saksena. 2003. First demonstration of a lack of viral sequence evolution in a nonprogressor, denning replication-incompetent HIV-1 infection. Virology 312:135-150.
    • (2003) Virology , vol.312 , pp. 135-150
    • Wang, B.1    Mikhail, M.2    Dyer, W.B.3    Zaunders, J.J.4    Kelleher, A.D.5    Saksena, N.K.6
  • 58
    • 0029861654 scopus 로고    scopus 로고
    • Resistance of human immunodeficiency virus type 1 to neutralization by natural antisera occurs through single amino acid substitutions that cause changes in antibody binding at multiple sites
    • Watkins, B. A., S. Buge, K. Aldrich, A. E. Davis, J. Robinson, M. S. Reitz, Jr., and M. Robert-Guroff. 1996. Resistance of human immunodeficiency virus type 1 to neutralization by natural antisera occurs through single amino acid substitutions that cause changes in antibody binding at multiple sites. J. Virol. 70:8431-8437.
    • (1996) J. Virol. , vol.70 , pp. 8431-8437
    • Watkins, B.A.1    Buge, S.2    Aldrich, K.3    Davis, A.E.4    Robinson, J.5    Reitz Jr., M.S.6    Robert-Guroff, M.7
  • 62
    • 0028057436 scopus 로고
    • Characterization of mutants of human immunodeficiency virus type 1 that have escaped neutralization by a monoclonal antibody to the gp120 V2 loop
    • Yoshiyama, H., H. Mo, J. P. Moore, and D. D. Ho. 1994. Characterization of mutants of human immunodeficiency virus type 1 that have escaped neutralization by a monoclonal antibody to the gp120 V2 loop. J. Virol. 68:974-978.
    • (1994) J. Virol. , vol.68 , pp. 974-978
    • Yoshiyama, H.1    Mo, H.2    Moore, J.P.3    Ho, D.D.4
  • 63
    • 10744230171 scopus 로고    scopus 로고
    • Novel single-cell-level phenotypic assay for residual drug susceptibility and reduced replication capacity of drug-resistant human immunodeficiency virus type 1
    • Zhang, H., Y. Zhou, C. Alcock, T. Kiefer, D. Monie, J. Siliciano, Q. Li, P. Pham, J. Cofrancesco, D. Persaud, and R. F. Siliciano. 2004. Novel single-cell-level phenotypic assay for residual drug susceptibility and reduced replication capacity of drug-resistant human immunodeficiency virus type 1. J. Virol. 78:1718-1729.
    • (2004) J. Virol. , vol.78 , pp. 1718-1729
    • Zhang, H.1    Zhou, Y.2    Alcock, C.3    Kiefer, T.4    Monie, D.5    Siliciano, J.6    Li, Q.7    Pham, P.8    Cofrancesco, J.9    Persaud, D.10    Siliciano, R.F.11
  • 64
    • 0036140259 scopus 로고    scopus 로고
    • A variable region 3 (V3) mutation determines a global neutralization phenotype and CD4-independent infectivity of a human immunodeficiency virus type 1 envelope associated with a broadly cross-reactive, primary virus-neutralizing antibody response
    • Zhang, P. F., P. Bouma, E. J. Park, J. B. Margolick, J. E. Robinson, S. Zolla-Pazner, M. N. Flora, and G. V. Quinnan, Jr. 2002. A variable region 3 (V3) mutation determines a global neutralization phenotype and CD4-independent infectivity of a human immunodeficiency virus type 1 envelope associated with a broadly cross-reactive, primary virus-neutralizing antibody response. J. Virol. 76:644-655.
    • (2002) J. Virol. , vol.76 , pp. 644-655
    • Zhang, P.F.1    Bouma, P.2    Park, E.J.3    Margolick, J.B.4    Robinson, J.E.5    Zolla-Pazner, S.6    Flora, M.N.7    Quinnan Jr., G.V.8

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.